Lovenox Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis
Conditions:   Cancer-associated Thrombosis;   Thrombocytopenia Interventions:   Biological: Enoxaparin;   Biological: Dalteparin;   Biological: Tinzaparin Sponsor:   Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 24, 2022 Category: Research Source Type: clinical trials